Dehydration

Are seniors being pressured into retirement homes by lack of community services?

Retrieved on: 
Tuesday, September 26, 2023
Uncertainty, Hair, Travel, Delirium, Nursing, Friends, Social, LTC, Long-term care, Hospital, Canada Health Act, Silver, Deficit spending, Risk assessment, Meal, Research, Ministry of Long-Term Care (Ontario), Senior, Ministry of Seniors and Accessibility, Ministry, Name, Dementia, The Weather Network, Retirement, Practitioner, Institutionalisation, Health, Confusion, City, Transport, Environment, Dehydration, Caregiver, Common, Residential care, Tourism, Health insurance, OECD

Ads for retirement homes often feature an older couple relaxing in comfortable surroundings, playing a board game or enjoying a meal with friends.

Key Points: 
  • Ads for retirement homes often feature an older couple relaxing in comfortable surroundings, playing a board game or enjoying a meal with friends.
  • They look well — and young for their age — with broad smiles and perfect silver hair.

Assisted living

    • In Canada, retirement homes (also known by other names like assisted living) are increasingly for-profit living facilities for older adults.
    • Across Canada, monthly fees range from $1,600 to over $6,000 for spaces ranging from 300 to 600 square feet.
    • In almost one-third of these cases, retirement home residents or their caregivers said they would be better off living elsewhere, such as in long-term care (LTC) homes, where they can receive 24-hour access to nursing and personal support services.

Unmet health-care needs

    • For example, retirement home residents living with dementia, and who can afford specialized memory care services, are less likely to move to a LTC home.
    • Clearly, the service and health-care needs of retirement home residents are not being met, nor were these being met in the community, compelling the move to a retirement home in the first place.
    • Despite evidence that the medical needs of retirement home residents have been growing more complex, the role of primary care medical providers is not regulated, nor is there much incentive to practice in these settings.
    • Dehydration related delirium (confusion) that could be addressed on site can instead lead to hospital admission and premature institutional care.

Designed for institutionalization

    • Our health-care system seems designed to foster premature institutionalization.
    • They will also allow older people greater choice over — and ability to afford — whatever lifestyle they prefer.
    • The Schlegel Chair endowment was a charitable donation to the University of Waterloo, and there is no personal obligation to the donor.

LM Energy Announces Sale of its Crude Oil Gathering Business

Retrieved on: 
Tuesday, September 26, 2023
Energy, Professional Services, Oil, Gas, Finance, Sale, LLP, Compression, Lea, Kirkland & Ellis, Dehydration, LM, Petroleum

LM Energy Holdings, LLC (“LM” or “the Company”) today announced that it has entered into definitive agreements to sell certain subsidiaries and assets related to its Touchdown Crude Oil Gathering System in Eddy and Lea counties, New Mexico.

Key Points: 
  • LM Energy Holdings, LLC (“LM” or “the Company”) today announced that it has entered into definitive agreements to sell certain subsidiaries and assets related to its Touchdown Crude Oil Gathering System in Eddy and Lea counties, New Mexico.
  • LM began the development of its crude oil gathering business in 2019 and has constructed over 130 miles of pipelines, two terminals with 136,000 barrels of combined storage capacity, and grew volumes from zero to approximately 75,000 barrels per day on a 100 percent greenfield basis.
  • “I want to start by thanking our customers for trusting in us to provide critical crude oil gathering services, which we never take lightly.
  • I also want to thank the entire LM team for their hard work and dedication safely developing and operating our crude oil gathering business over the last four years,” said Elliot Gerson, Chief Executive Officer at LM.

scPharmaceuticals Announces Positive Feedback from Two FDA Meetings on Key Long-Term Growth Initiatives

Retrieved on: 
Tuesday, September 19, 2023
Overload, Furosemide, PK, Hypersensitivity, NYHA, Congestion, Embolism, Hypoproteinemia, Organic acid, Heart failure, Hospital, Urine, Creatinine, Cirrhosis, Dehydration, Glucose, Tinnitus, Deafness, Huber loss, Edema, Hepatic encephalopathy, Oliguria, History, Solubility, Type, Diuresis, Uric acid, New York Heart Association Functional Classification, Kidney, Bruise, Shanda, Investigational New Drug, HIV disease progression rates, Patent, Patient, Physician, Ototoxicity, Urinary retention, Erythema, Azotemia, Ascites, Coma, Type D, Growth, Diagnosis, Blood volume, FDA, Benign prostatic hyperplasia, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, CKD, Cerebral edema, CO2, Thrombosis, BUN, Food, Kidney disease, Anuria, Pharmaceutical industry

BURLINGTON, Mass., Sept. 19, 2023 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs, today announced that the Company has received positive feedback from the U.S. Food and Drug Administration (FDA) on two key long-term growth initiatives.

Key Points: 
  • The Company also announced today feedback from a Type D meeting with the FDA pertaining to the potential expansion of the FUROSCIX label to include treatment of edema due to fluid overload in patients with CKD.
  • In its feedback, the FDA confirmed that no additional clinical studies are needed to expand the indication, provided that the Company demonstrates an adequate PK and pharmacodynamic bridge to the listed drug, furosemide injection, 10 mg/mL.
  • CKD is a progressive disease characterized by worsening renal function over time, resulting in frequent episodes of fluid overload that are treated with loop diuretics.
  • “We are very pleased to have reached alignment with the FDA on the advancement of these two very important long-term growth initiatives for our company,” stated John Tucker, Chief Executive Officer of scPharmaceuticals.

Safety Shot to Develop Detox Product for Alcohol Poising, Plans to File IND with U.S. FDA

Retrieved on: 
Monday, September 18, 2023
Cognition, Seizure, Cardiac arrest, Central nervous system, Dehydration, Safety, Hypothermia, Choking, Ambulance, Asphyxia, Brain damage, Jupiter, CNS, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Death, Hospital, Health, FDA, IND, Food, Pharmaceutical industry

The Safety Shot beverage, set to launch Q4 2023, is the first patented beverage on Earth that helps people feel better faster by reducing blood alcohol content and boosting clarity.

Key Points: 
  • The Safety Shot beverage, set to launch Q4 2023, is the first patented beverage on Earth that helps people feel better faster by reducing blood alcohol content and boosting clarity.
  • The Safety Shot platform works through four different Mechanisms of Action including improving central nervous system (CNS) activity, cognition, and motor cortex function.
  • “We believe a concentrated form of Safety Shot could offer an easy-to-administer, immediately supportive aid or treatment for acute alcohol consumption to help prevent alcohol poisoning and related deaths.
  • “We anticipate filing an investigational new drug (IND) application with the U.S. Food and Drugs Administration (FDA) for this alcohol poisoning related indication.”

Allegheny Health Network Announces Expansion of Pediatric Services at Wexford Hospital

Retrieved on: 
Wednesday, September 20, 2023
Olive, ENT, Loss, Pediatrics, Therapy, Ear, Urinary tract infection, Education, Life, Dehydration, Parent, Disability, Anxiety, Fear, ADHD, Brain, Attention deficit hyperactivity disorder predominantly inattentive, Nose, DO, RSV, AHN, Wii Fit, Patient, Nursing, Child, Person-centered therapy, Spectrum, Observation, Hospital, Starlight Children's Foundation, Health, Trauma, Dyslexia, Family, Allegheny Health Network, Book, Helsinki University Central Hospital, Caregiver, Northwest Bank, Dietary supplement, MD

WEXFORD, Pa., Sept. 20, 2023 /PRNewswire-PRWeb/ -- Allegheny Health Network (AHN) announced today that it is expanding the scope of its pediatric services and capabilities at Wexford Hospital, providing children and families in the northern suburbs of Pittsburgh with new, convenient access to high-quality inpatient care for children with acute medical conditions as well as those with orthopaedic and ear, nose and throat (ENT) conditions. The expansion also includes specialized accommodations for neurodiverse children.

Key Points: 
  • With this latest expansion of services, pediatric patients who require admission to the hospital for extended observation or medical treatment can now do so at AHN Wexford.
  • A cornerstone of the pediatric expansion at AHN Wexford is the addition of a team of pediatric hospitalists, nurses specifically trained in pediatrics, pediatric physical and occupational therapists and a child life specialist, all of whom provide comprehensive care for children and their families.
  • The hospital is now one of three within Allegheny County with 24/7 pediatric hospitalist coverage.
  • "Pediatric hospitalists are available around-the-clock to care for children suffering from acute conditions which could include respiratory infections, gastrointestinal illness, dehydration, and orthopaedic injuries, among others," said Evelina Krieger, MD, director of pediatric hospital medicine at AHN Wexford.

Buffalo Games Recalls Chuckle & Roar Ultimate Water Beads Activity Kits Due to Serious Ingestion, Choking and Obstruction Hazards; One Infant Death Reported; Sold Exclusively at Target

Retrieved on: 
Thursday, September 14, 2023
Human, CPSC, Target Corporation, Dehydration, Choking, Bowel obstruction, UPC, Target, U.S. Consumer Product Safety Commission, Vomiting, Risk, Child, Buffalo Games, Death, Laughter, Online shopping, Dietary supplement

The U.S. Consumer Product Safety Commission (CPSC) and Buffalo Games LLC, of Buffalo, New York, are announcing the recall of about 52,000 Chuckle & Roar Ultimate Water Beads Activity Kits due to ingestion, choking and obstruction hazards.

Key Points: 
  • The U.S. Consumer Product Safety Commission (CPSC) and Buffalo Games LLC, of Buffalo, New York, are announcing the recall of about 52,000 Chuckle & Roar Ultimate Water Beads Activity Kits due to ingestion, choking and obstruction hazards.
  • Buffalo Games received one report of a 10-month-old child's death from swallowing the recalled water beads in July 2023 in Wisconsin.
  • Consumers should immediately stop using and take the recalled Chuckle & Roar Ultimate Water Beads Activity Kits away from children.
  • The recalled Chuckle & Roar Ultimate Water Beads Activity Kits were sold exclusively at Target stores nationwide and online at Target.com from March 2022 through November 2022 for about $15.

Oliveda International, Inc. Announces Launch of OliveMush Coffee Replacement Based on Hydroxytyrosol

Retrieved on: 
Wednesday, September 13, 2023
Olive, OTC Markets Group, Restless, Headache, ESFA, Dehydration, Cardamom, Anxiety, Tree, Caffeine, Cell, Ginger, Oleuropein, Cordyceps, Insomnia, Dizziness, Maria Lluïsa Oliveda Puig, Coffee, Heart rate, Soap, Beauty

Santa Monica, CA, Sept. 13, 2023 (GLOBE NEWSWIRE) -- Oliveda International, Inc. (OTC Pink: OLVI) today announced the launch of the world's first coffee replacement based on the bioactive ingredient hydroxytyrosol and olive leaf, which will now be presented on September 15-16 by the Company’s subsidiary, Olive Tree People, in Los Angeles.

Key Points: 
  • Santa Monica, CA, Sept. 13, 2023 (GLOBE NEWSWIRE) -- Oliveda International, Inc. (OTC Pink: OLVI) today announced the launch of the world's first coffee replacement based on the bioactive ingredient hydroxytyrosol and olive leaf, which will now be presented on September 15-16 by the Company’s subsidiary, Olive Tree People, in Los Angeles.
  • OliveMush was created in spring 2023 by Oliveda founder, Thomas Lommel, who has already popularized the world's first Olive Matcha, also based on his ground olive leaves.
  • With 0% caffeine, OliveMush is a coffee replacement and magical superfood at the same time.
  • We at Olive Tree People protect feral mountain olive trees by purchasing large estates, cultivating trees, and eco-certifying them.

Ardelyx Showcased Encouraging Data on Treatment Satisfaction and Efficacy of IBSRELA® (tenapanor) for IBS-C at GHAPP 2023

Retrieved on: 
Monday, September 11, 2023
Rat, Diarrhea, CSBM, Dehydration, Irritable bowel syndrome, IBS-C, Quality of life, Constipation, Tenapanor, Abdominal pain, SBM, Death, Incidence, AS3, IBS, Risk, Analysis, Bloating, Poster, MPH, Conference, Human, Food, Safety, Abdominal distension, Pharmaceutical industry, Birth control, MD, Patient

There is a growing body of data that continues to expand our understanding of IBSRELA and how it works to provide symptomatic relief.

Key Points: 
  • There is a growing body of data that continues to expand our understanding of IBSRELA and how it works to provide symptomatic relief.
  • These data provide additional evidence of IBSRELA’s safety and efficacy, bringing much needed relief to those living with IBS-C,” said Laura Williams, MD, MPH, chief medical officer of Ardelyx.
  • The Phase 3 T3MPO-2 trial randomized patients to tenapanor 50 mg twice a day or matched placebo for 26 weeks of treatment.
  • This post hoc analysis found that IBSRELA-treated patients with IBS-C reported a reduction in abdominal symptom scores compared to placebo.

CF Industries and POSCO Evaluating Joint U.S.-Based Clean Ammonia Project and Long-Term Clean Ammonia Offtake Agreement into South Korea

Retrieved on: 
Thursday, September 14, 2023
Environment, Other Energy, Chemicals, Plastics, Manufacturing, Sustainability, Energy, Other Natural Resources, Agriculture, Natural Resources, Hydrogen, Dehydration, Policy, ATR, Carbon, IRA, FEED, Ammonia, ExxonMobil, CO2, SMR, CCS, CF Industries, CF, POSCO, Coal

CF Industries Holdings, Inc., the world’s largest producer of ammonia, and POSCO Holdings Inc. (POSCO), South Korea’s largest steelmaker as well as a leader in energy trading and power generation, announced today that the companies are evaluating a joint venture to construct a low-carbon clean ammonia plant at CF Industries’ Blue Point Complex in Ascension Parish, Louisiana, United States, along with long-term low-carbon clean ammonia offtake into South Korea.

Key Points: 
  • CF Industries Holdings, Inc., the world’s largest producer of ammonia, and POSCO Holdings Inc. (POSCO), South Korea’s largest steelmaker as well as a leader in energy trading and power generation, announced today that the companies are evaluating a joint venture to construct a low-carbon clean ammonia plant at CF Industries’ Blue Point Complex in Ascension Parish, Louisiana, United States, along with long-term low-carbon clean ammonia offtake into South Korea.
  • As part of their evaluation, CF Industries and POSCO will initiate a front-end engineering and design (FEED) study on autothermal reforming (ATR) ammonia production technology.
  • Should the project move forward, POSCO expects to import low-carbon clean ammonia from the facility to South Korea to support decarbonization of POSCO's own and third-party coal-based power generation facilities.
  • Additionally, CF Industries is constructing North America’s first commercial scale green ammonia capacity at its Donaldsonville Complex, enabling up to 20,000 tons of green ammonia production beginning in 2024.

Elanco Launches Varenzin™-CA1 (molidustat oral suspension) – the First-of-its-Kind Oral Treatment for Anemia in Cats with Chronic Kidney Disease

Retrieved on: 
Thursday, September 7, 2023
Health, Consumer, Agriculture, Natural Resources, Pets, Pharmaceutical, Veterinary, Hypersensitivity, Seizure, Acromegaly, Syringe, Disease, FDA Center for Devices and Radiological Health, Somatic symptom disorder, Chronic kidney disease, Hypersalivation, Breeding, Veterinarian, Dehydration, Oxygen, Weight loss, Food and Drug Administration, Bone marrow, Ageing, Quality of life, Nutrient, HCT, Medicine, Appetite, Coronary thrombosis, Vomiting, ELAN, Animal, Euthanasia, Patient, Liver, Lethargy, Anemia, Blood, Pet, PCV, Heart rate, FDA, Veterinary medicine, Death, CKD, Woman, Hematocrit, NYSE, Polycythemia, Food, Cat, Dietary supplement, Medical imaging, Poultry farming, Elanco

CKD is common among mature and senior cats, occurring in about 15-30% of feline patients over 12 years old.

Key Points: 
  • CKD is common among mature and senior cats, occurring in about 15-30% of feline patients over 12 years old.
  • “Chronic kidney disease is not curable, so veterinarians and pet owners are focused on improving quality of life and slowing disease progression in affected cats,” said Dr. Melinda Wood, Specialty Consulting Veterinarian at Elanco.
  • Varenzin-CA1 is indicated for the control of nonregenerative anemia associated with chronic kidney disease (CKD) in cats.
  • Elura has not been evaluated in cats younger than 5 months of age or in breeding, pregnant or lactating cats.